Top 50 Biotech Startup Investors in Spain in November 2024

Investor	Biotech Spain investments
Centre for the Development of Industrial Technology (CDTI)	24
Criteria Venture Tech	18
SODENA	13
Inveready	12
ENISA	12
Invivo Capital Partners	10
Capital Cell	10
Asabys Partners	9
Ysios Capital	9
BeAble Capital	8
Alta Life Sciences	8
Clave	8
Bullnet Capital	7
CRB Inverbío	7
Xesgalicia	7
SOSV	6
Moira Capital Partners	5
BStartup	5
CDTI	5
Clave Mayor	4
Seed Capital Bizkaia	4
Kurma Partners	3
Clave Capital	3
Angels Capital	3
Amadeus Capital Partners	3
AdBio partners	3
Kinled Holding	2
Healthequity	2
AVANTECA Partners	2
Talis Capital	2
Speedinvest	2
BoxOne Ventures	2
Eatable Adventures	2
Blue Horizon Corporation	2
Monte Carlo Capital	2
Fondo Bolsa Social	2
WA4STEAM	2
Grupo Ferrer Internacional	2
Juan Knuth	2
BAGi	2
Union Square Ventures	2
Josep Carreras Leukaemia Research Institute	2
Grow Venture Partners	2
Charme Capital Partners	2
Santander	2
Kereon Partners	2
Amino Collective	2
Pirate Impact	2
EASO Ventures	2
Archipelago Next	2

The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .

Investment focus

Biotechnology, Health Care, Software
Funding Round, Seed, Grant
Spain, United States, France

Portfolio highlights

Tebrio — At the rate that the world is growing, we’ll only have enough food to feed 50% of our future population by 2050 and introducing novel proteins into the food value chain that are rich in amino acids and use less water and arable land is the only solution forward for mankind and the planet, which is why, in 2014, Adriana Casillas and Sabas de Diegofounded Tebrio, the world’s leading carbon-negative, zero-residue insect biotechnology company, which tackles climate change and the world food crisis by breeding and transforming rich amino acid mealworms into three main co-products: (i) sustainabe premium fish, pet and animal feed (ii) biofertilizer for plant nutrition that acts as a natural pest repellent (iii) chitosan to manufacture biodegradable plastic that disolves in water. Our carbon negative pilot farm produces 500 tons of co-products a year, does not emit greenhouse gases like ammonia or methane, uses 98% less water and 90% less arable land than other animal and plant protein farms, and is the only company in our industry in Spain that has received an ISO9001 certification, which guarantees the quality of our products. Thanks to our current operations, we have secured an undisclosed Series A round, which we are using to develop a EUR 50 million insect farm that will take us from a 500 tn to a 100.000 tns production of co-products a year and will be the largest of its kind in the world. Company Key Metrics: • Tebrio has 8 industrial patents in 150 countries • Tebrio’s operations are carbon negative, zero residue, and we do not emit greenhouse gases like ammonia or methane • With the same amount of natural resources, we are able to produce 500% more protein for fishmeal and animal feed than plant protein and livestock farms • Our protein for fish and animal feed is 90% digestible, 70% protein, high in essential amino acids and unsaturated fat • Tebrio was the first certified producer in the world of mealworm protein for fish and animal feed and biofertilizer for plant nutrition • Our tech powered biofertilizer has 10x more nutrients than other organic fertilizers and thanks to its properties, acts as a natural pest repellent • We are the only Spanish company in our industry with an ISO9001 certification • We are building the world’s largest insect farm, which will produce 100.000 tons of co-products a year for animal feed and plant fertilization • We use big data and 4.0 industries to industrially produce and control the Tenebrio Molitor insect
Zeleros — Leaders in the development of hyperloop technologies, we are your new electrification & automation partner in the mobility sector.
INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.

Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Pre-Seed to Series C) managing more than €300M of AUM.

Investment focus

Software, Biotechnology, E-Commerce
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

Enline — Technology for Power Systems, TRANSMISSION AND DISTRIBUTION SYSTEM OPERATORS, INDUSTRY AND MINING, ENGINEERING & CONSTRUCTION, INSURANCE AND CONSULTANCY, UTILITIES & POWER GENERATION, ENLINE MONITORING SYSTEM, ENLINE DYNAMIC LINE RATING, ENLINE FAULT LOCATION, ENLINE POWER OPTIMIZATION .
Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
KIT-AR — Reduce time and costs spent fixing errors on your manufacturing shopfloor with quality assurance and augmented reality- Click in to find how!

SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of GrupoCorporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.

Investment focus

Biotechnology, Health Care, Software
Debt Financing, Funding Round, Seed
Spain, United Kingdom

Portfolio highlights

MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
MainRail — KEY BENEFITS Reduce maintenance costs by preventing unscheduled repairs and optimizing resource allocation. Increase the capacity of your network by minimizing the risk of service unavailability thanks to
Pyroistech — Pyroistech uses spectroscopy to create custom solutions for the industrial sector. With this method, a sample is illuminated, and the amount of light reflected or transmitted through it is measured. It is useful in a variety of fields: Agri-food industry, Construction, Medicine, and Other sectors.

We are a leading asset manager in Spain. We invest in early-stage VC, growth VC, venture debt, strategic public equity, private equity and infrastructure. Our different strategies allow us to provide financing solutions to companies throughout their life-cycle.

Investment focus

Software, Biotechnology, Information Technology
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

Nanusens — Nanusens shrinks MEMS sensors and builds nanoscale sensors (NEMS – Nano Electro Mechanical Systems) along with the control electronics using standard CMOS processes.
IENAI SPACE — IENAI SPACE develops efficient ionic-liquid electric propulsion systems and mission analysis for nano-satellites. The company provides propulsion modules customized for each particular platform and mission, from 2U to 12U, from RAAN-spacing to Earth-Moon transits or de-orbiting.Its versatile Tailored Taylor Thruster is highly scalable in specificimpulse and thrust. It is based on a novel iteration of electrospray thrusters, which boast high theoretical efficiencies for electric propulsion technologies in the low power range. In combination with its decreased form factor, meaning less propellant on-board, making this technology attractive in constrained volumes.IENAI SPACE was founded in 2019 and is headquartered in Madrid, Spain.
Scaleup Finance — Improve your financial management

ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.

Investment focus

Software, Health Care, E-Commerce
Seed, Debt Financing, Pre-Seed
Spain, United States, France

Portfolio highlights

Remolon — Remolon's mission is to reduce food losses and waste while also building a better food system for all.
Ubicuity — Ubicuity is a software platform that allows to create and manage advanced audiovisual experiences for space managers and content providers.
Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.

Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.

Investment focus

Biotechnology, Health Care, Life Science
Seed, Funding Round, Series A
Spain, France, Belgium

Portfolio highlights

EsoBiotec — EsoBiotec is a Belgian biotechnology business focused on the discovery of novel cancer therapies.EsoBiotec's objective is to enable the human body to fight cancer by delivering 'in vivo' cell engineering to patients.
Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.

Investment focus

Health Care, Biotechnology, Medical
Equity Crowdfunding, Funding Round, Seed
Spain, United States, United Kingdom

Portfolio highlights

Exheus — Exheus tells everything that you need to know to take maximum care of yourself and avoid risks to your health, exheus is much more than a DNA test that only indicates which genes you have.
MediQuo — MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction. Healthcare today has 75% of unnecessary medical visits that could be taken in the distance, and the vast majority of health professionals are using messaging platforms such as WhatsApp to communicate with patients or other health professionals.MediQuo is a chat-based app specialised in health, GDPR and health data compliant, giving professionals time control, incorporating patient medical history and phone privacy. Allowing also video and audio communication. It is a place for discussion, appointments or medical consultation with your doctor or any new health professional. Also includes immediate 24/7 medical response and a network, for health information and professional discovery. We have done already 1M consultations and got 600k app downloads. Our Google Play Ratings are 4,6 (with 6k reviews). We are amongst the top health apps in Spain and Latam.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Investment focus

Biotechnology, Medical Device, Health Care
Series A, Seed, Series B
Spain, France, Belgium

Portfolio highlights

Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases
INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
Spain, United States, Switzerland

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
Engrail Therapeutics — Engrail delivers transformational therapies that improve the lives of patients with devastating neurologic, neuropsychiatric, and neurodevelopmental disorders.

BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.

Investment focus

Biotechnology, Manufacturing, Software
Pre-Seed, Seed, Funding Round
Spain, Italy

Portfolio highlights

Ecogranular — Ecogranular is a company that is revolutionizing the present landscape of biological wastewater treatment by reducing water footprints, operating costs, and improving water quality.
DAN*NA — DAN*NA’s mission is to accelerate the world's transition to sustainable technological materials. DAN*NA is a bioengineering company dedicated to the development of advanced biomaterials and bioplastics for the technology sector. From organic waste we obtain our raw material that is transformed by molecular technology, green chemistry processesand Artificial Intelligence into a bio-based material with high added value. Our development is a model in efficiency and sustainability. Our goal is to introduce a highly technical and sustainable materials to the technology market, with the reduction of electronic waste generated by the technology sector and the reduction of organic waste.
Cramik Additive Solutions — TECHNOLOGY BASED COMPANY

Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Funding Round, Seed
Spain, United States

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.

Clave is an investment management company.

Investment focus

Biotechnology, Health Care, Software
Seed, Series A, Funding Round
Spain, Chile, Switzerland

Portfolio highlights

MainRail — KEY BENEFITS Reduce maintenance costs by preventing unscheduled repairs and optimizing resource allocation. Increase the capacity of your network by minimizing the risk of service unavailability thanks to
Sincrolab — Descubre Sincrolab, el tratamiento digital que utiliza inteligencia artificial para mejorar los procesos cognitivos. Con eficacia validada en TDAH,...
homedoctor — Homedoctor is an online medical care app that offers medical video consultations. With Homedoctor's health robot, users can keep an eye on their own vital signs and record the information in their medical records to look for abnormalities in their internal and external organs. Specialists from Homedoctor's team in pediatrics, gynecology,internal medicine, dermatology, psychiatry, pneumonia, sports, and rehabilitation medicine, and nutrition help patients in a live video consultation while relying on the tools to provide an accurate diagnosis.

Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses

Investment focus

Software, Information Technology, Enterprise Software
Funding Round, Seed, Series A
Spain, United States, Mexico

Portfolio highlights

MLCode — Accelerated by massive AI/ML adoption, Data is to become the most critical resource for Enterprises. MLCode vision is to protect that Data. MLCode: Data Security Automation.
Inspiration-Q — Inspiration-Q focuses on developing and commercializing software solutions inspired by quantum computing for financial applications.
Mapsi Photonics — Mapsi Photonics focuses on developing macroporous silicon infrared filters for industrial applications like gas identification and thermal vision, aiming to improve performance, cost, resolution, operational range, and environmental footprint.

CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies

Investment focus

Medical, Health Care, Biotechnology
Series A, Funding Round, Seed
Spain, Mexico

Portfolio highlights

Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
Biocross — Biocross, S.L., a biotechnology company, develops blood tests for the diagnosis of Alzheimer’s diseases to neurologists.
Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.

XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.

Investment focus

Software, Biotechnology, Pharmaceutical
Seed, Funding Round, Pre-Seed
Spain, Portugal

Portfolio highlights

Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
Appentra — In the software world, new technologies have recently put on the hands of companies and developers highly powerful tools which involve a leap in computing capabilities. First, heterogeneous multicore systems have become small and affordable supercomputers. Second, Artificial Intelligence, Machine Learning, Deep Learning, and big data arerevolutionizing entire economic sectors. These powerful tools were up until now only accessible to a minority of organizations with massive resources but finally they have become mainstream. However, to take advantage of these powerful capabilities, companies need to adopt the computing technologies created for years in (HPC) market, particularly parallel computing. PARALLELWARE ANALYZER is the most complete and fast software aimed to enable developers to overcome the complexity of parallel programming. Appentra is a Deep Tech global company that delivers products based on the Parallelware technology, a unique approach to static code analysis specialized in concurrency and parallelism. Our aim is to make parallel programming easier, enabling everyone to make the best use of parallel computing hardware from the multi-cores in a laptop to the fastest supercomputers.
Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Moira Capital Partners is private equity firm

Investment focus

Biotechnology, Information Technology, 3D Technology
Funding Round, Series A, Private Equity
Spain

Portfolio highlights

NeuronUP — NeuronUP is a platform that provides professionals the ability to access real, when and where they want their exercise routines and their patients time manager and interact directly with their team of professionals in a specialized environment. All this generates a continuous updating of information and content platform, arising from theinter-professional dialogue.
Voovio — Voovio's Simulation Software enables the process industry to avoid errors during SOP execution, reducing downtime & increasing safety in operations & maintenance.
Geodesic Innovations — Geodesic Innovations is a water-saving and purification company that develops advanced water treatment, conservation, and regeneration systems to offer services for disinfection and improvement of water quality without using chemicals.

A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Pre-Seed
Spain, United States

Portfolio highlights

toddl.co — Reserva clases, campamentos y eventos para tus hij@s en 3 clics
Remuner — The sales compensation platform that helps you align your company and employee goals by automating all aspects of incentive plans.
Emely AI — Emily.AI enables the adaptation to various environments and patient conditions, reducing or eliminating the need for medical supervision. The company has developed an oxygen therapy medical device that uses artificial intelligence to dynamically adjust to each patient's specific needs.

Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Debt Financing
Spain, United States, Mexico

Portfolio highlights

Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
Atlas Molecular Pharma — Latest News Your browser does not support the video tag.

Clave Mayor is a management company of closed investment entities based in Navarra.

Investment focus

Software, Biotechnology, Medical
Funding Round, Seed, Series A
Spain, Germany, United States

Portfolio highlights

MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
Predictheon — Predictive monitoring for clinicians. Real-time predictions about patient health status to personalize medical care, adjust and individualize therapy, and improve safety.

Seed Capital de Bizkaia is a Regional Council company affiliated to Biscay Regional Council's Department of Economic Development and Innovation (Departamento de InnovaciÃ³n y PromociÃ³n EconÃ³mica de la DiputaciÃ³n Foral de Bizkaia) whose aim is to manage a Venture Capital Fund called â€œSeed Capital Bizkaia, F.C.R.â€.

Investment focus

Software, Biotechnology, Health Care
Seed, Funding Round, Series A
Spain

Portfolio highlights

Fisify — Fisify is a physical treatment clinic, that creates technologies to make people's life easier and offers the requested services as well as commercial communications.
H2SITE — We provide fully integrated systems to produce on-site high quality hydrogen.
CLCircular — CL Circular: Transforming Global Logistics with Circular Technology. Our mission is to make real-time visibility technology accessible

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Series B, Seed
France, Switzerland, Spain

Portfolio highlights

SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
PanTera — PanTera wants to bring a new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for personalised treatment of tumors
Spotlight Medical — Spotlight Medical is a precision medicine company striving to free all patients from cancer through a better understanding of each patient’s unique disease. We develop advanced AI tests that enhance treatment selection by leveraging decades of patient data. This ensures personalized and effective care for each individual, significantly improvingpatient outcomes and quality of life. By closely collaborating with physicians, we create impactful tests that address critical unmet clinical needs, opening a new era in cancer care.

Clave Capital is an independent asset management company that specializes in investment strategy.

Investment focus

Biotechnology, Health Diagnostics, Health Care
Seed, Funding Round
Spain

Portfolio highlights

MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
Nanological — Nanological is a public research organization, that focuses on pathogen identification devices. Nanological is a team of biosensing experts including physicists, biologists, data scientists, finance and business development experts, and clinical validation specialists.
ADmit Therapeutics — ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.

Angels Capital philosophy is to find and support at 1 able to lead a project. Their goal is to support the entrepreneurial, helping to create new businesses, help grow their business sector, generate employment and create wealth.

Investment focus

Software, E-Commerce, Financial Services
Seed, Angel, Funding Round
Spain, United States

Portfolio highlights

Zexel — Zexel is an influence campaign management software streamlining internal financial administrative processes between the agency and the influencer.
Solved — Solved develops intuitive software that replaces the manual process of incident management and root-cause analysis in a collaborative way across the whole food supply chain.Most of the food factories record incidents on paper or Excel sheets. For this reason, they lose a lot of information and a lot of time when managing internal incidents andcustomer complaints.This problem gets even bigger when the entire supply chain (including supermarkets, big corporates, factories…) is involved in the incident resolution process. Everyone works on their own closed system, and the exchange of information about incidents is done through mountains of emails and endless phone calls. That makes collaboration and communication chaotic.As a result, incidents are never fully resolved and factories will keep having the same issues without acting on root causes; which means that large amounts of resources are wasted.
FitnessKPI — FitnessKPI is a software company that offers business analytics services for sports and fitness centers.

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Investment focus

Software, Artificial Intelligence, Information Technology
Series B, Seed, Series A
United Kingdom, United States, Spain

Portfolio highlights

PhoreMost — PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savingsonto patients.
Riverlane — Riverlane's mission is to make quantum computing useful far sooner than previously imaginable, starting an era of human progress as significant as the industrial and digital revolutions.
qomodo — Intelligent IOT Embedded Security. We protect commercial or industrial IOT devices from the threats of the internet. Driven by leading intelligence and machine learning, our anomaly detection allows us to protect even the simplest IOT devices.

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Seed, Series A, Funding Round
France, Spain, Belgium

Portfolio highlights

Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Investment focus

Biotechnology, Health Care, Financial Services
Seed, Funding Round, Series A
United Kingdom, United States, Switzerland

Portfolio highlights

Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.

Healthequity is a venture capital company specializing in early-stage projects in the health sector: medical devices, biotechnology and healthcare services. It is a fund promoted by the Official College of Physicians of Barcelona and the financial group Riva y Garcia that is looking for projects to make their first investments. Healthequity has ateam of professionals with complementary experience, with the scientific-technical and financial know-how necessary to analyze and make investments contributing value to the investee company. In addition, it has a network of contacts and key strategic relationships in the health ecosystem.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series D
Spain, Switzerland

Portfolio highlights

SANIFIT — A new approach to calcification disorders.
Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Versantis — Versantis is a Swiss pharmaceutical company, Spin-off of ETH Zurich, developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide. Its lead candidate, VS-01, iscurrently at preclinical stage and has the potential to be the first drug for acute liver disease simultaneously supporting multiple failing organs. VS-01 targets 3 rare indications and received an Orphan Drug Designation in ALF. In addition, Versantis’ pipeline promises to improve patients’ outcome in other medical fields; VS-02 and VS-03 are developed for chronic liver diseases and for the treatment of drug intoxications, both representing large market opportunities and significant upsides for Versantis.

A privately held asset management company that invests in early-stage life science companies.

Investment focus

Biotechnology, Health Care, Security
Seed, Funding Round
Spain, Switzerland

Portfolio highlights

Bearmind — Bearmind developing technology for monitoring and real-time analysis of head impact in athletes.
Nanoligent — Nanoligent is a biotech company, spin-off of the Universitat Autònoma de Barcelona (UAB) and Institut de Recerca de l'Hospital de la Santa Creu I Sant Pau. We are dedicated to drug design and development of targeted-therapeutic biologics .Nanoligent mision is to improve the life of patients by designing new medicines that selectively targetthe cells affected by disease. With this approach we develope treatments that are more effective and have fewer adverse effects than classical drugs.
Onena Medicines — Onena Medicines is a biotechnology company that creates innovative biological medicines to address the large unmet clinical need for breast cancer and other serious orphan illness.

We back founders who see the future differently.

Investment focus

Software, Information Technology, E-Commerce
Series A, Seed, Series B
United Kingdom, United States, Germany

Portfolio highlights

Acin — Acin delivers at speed by combining unique industry data, AI and high touch expertise. The trusted partner, built by the industry, for the industry
Laced — Discover the latest sneaker releases with Laced. The UK and Europe's authentic sneaker marketplace, discover coveted styles from Nike, Air Jordan, Yeezy, New Balance and more. Buy and sell now with Laced.
Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.

Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.

Investment focus

Software, FinTech, Financial Services
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

autone — Autone is a SaaS operational platform enabling retail & CPG businesses to make optimal decisions easily and quickly
AllFocal Optics — AllFocal Optics revolutionizes display technology through groundbreaking nanophotonic solutions.
Recyda GmbH — All-in-one Packaging Recyclability Management

BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.

Investment focus

Biotechnology, Health Care, Software
Seed, Pre-Seed, Series A
Canada, United States, Spain

Portfolio highlights

Talus Bio — Talus Bioscience combines functional proteomics, automated biology, and machine learning to target hard-to-treat transcription factors driving cancer & beyond.
CytoTronics — CytoTronics allows you to visualize live cell function in real time and at scale using a revolutionary approach to studying cell biology, powered by microchips.
Axonis Therapeutics — AXONIS Therapeutics, Inc. is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders.

We identify and support the most innovative European food startups and help them to thrive in the global market

Investment focus

Food and Beverage, Food Processing, Agriculture
Seed, Series A
Spain, Italy

Portfolio highlights

Innomy — We developed a new generation of meat and take care of the planet.
FoodSeed — FoodSeed, the national Agrifoodtech program in Italy, along with CDP Venture Capital Sgr, Fondazione Cariverona, and UniCredit.
Foreverland — Foreverland Food is an Italian food-tech startup.

Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Series A, Funding Round
United States, United Kingdom, France

Portfolio highlights

WOW EARN — WOW EARN is a decentralized DeFi platform offering Web3 applications including staking, mining, NFT minting, DEX, GameFi, DAO governance, and multi-chain support. Join the future of decentralized finance.
foodforecast — AI supported solution to reduce food waste.
New School Foods — Whole-muscle, plant-based seafood

Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).

Investment focus

Medical Device, Financial Services, Medical
Seed, Funding Round, Series A
United States, United Kingdom, Spain

Portfolio highlights

Chaiz — Chaiz is the first digital marketplace for extended car warranties. Search, compare and buy service plans from top providers completely online.
LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Fondo Bolsa Social venture capital fund that invests into startups or new companies that generates positive social and environmental impact.

Investment focus

SaaS, Software, B2B
Seed, Funding Round, Pre-Seed
Spain

Portfolio highlights

toddl.co — Reserva clases, campamentos y eventos para tus hij@s en 3 clics
CubicUp — CubicUp is the person of confidence that accompanies you in your project of Reform from Begin to Finish.
Punto Health — A digital solution for management of Alzheimer's disease and other dementias. PuntoClinic for healthcare providers and PuntoCare for patients and carers.

WA4STEAM is an all women angels investment group delivering worldwide access to seed capital for women entrepreneurs led startups in STEAM Science, Technology, Engineering , Architecture & Architecture and Mathematics

Investment focus

Health Care, Artificial Intelligence, Biotechnology
Seed, Pre-Seed, Series A
Spain

Portfolio highlights

Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
Poseidona — Sustainable proteins from algal waste and invasive biomass
IENAI SPACE — IENAI SPACE develops efficient ionic-liquid electric propulsion systems and mission analysis for nano-satellites. The company provides propulsion modules customized for each particular platform and mission, from 2U to 12U, from RAAN-spacing to Earth-Moon transits or de-orbiting.Its versatile Tailored Taylor Thruster is highly scalable in specificimpulse and thrust. It is based on a novel iteration of electrospray thrusters, which boast high theoretical efficiencies for electric propulsion technologies in the low power range. In combination with its decreased form factor, meaning less propellant on-board, making this technology attractive in constrained volumes.IENAI SPACE was founded in 2019 and is headquartered in Madrid, Spain.

Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.

Investment focus

Biotechnology, Wellness, Biopharma
Series A, Funding Round
Spain

Portfolio highlights

Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
ABAC Therapeutics — ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximizethe chance of success in clinical development.

Juan Knuth

Investment focus

Health Care, Biotechnology, Digital Media
Seed, Series A
Spain

Portfolio highlights

Devicare — Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The company's medical devices are useful in measuring the level of biomarkers in body fluids such as saliva, tears, sweat, sputum, feces, urine or blood, enabling medical professionals to detect and treat various infectious diseases.

BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.

Investment focus

Internet, Health Care, Information Technology
Seed, Angel, Funding Round
Spain, Norway, Switzerland

Portfolio highlights

Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
The Smart Lollipop — The Smart Lollipop is the non-invasive medical device in the shape of a lollipop for the diagnostic and disease monitoring through a saliva sample. The sweetest lab is The Smart Lollipop.

Union Square Ventures is a venture capital firm based in New York City.

Investment focus

Software, Financial Services, FinTech
Series A, Series B, Series C
United States, United Kingdom, Canada

Portfolio highlights

SuppCo — SuppCo helps people find health supplements, manage supplement routines, and track their health.
Ghost — The backbone for retail brands to optimize their inventory lifecycle.
Glow Labs — Solar farms on the Glow network are paid with GLW tokens for electricity output and stablecoins for carbon credits. According to the business, their incentive model prioritizes incentives for solar farms with the greatest environmental benefit, focusing on places where clean energy can best balance high carbon emissions.

International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.

Investment focus

Life Science, Biotechnology
Seed
Spain

Portfolio highlights

OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People

Investment focus

Biotechnology, Robotics, Software
Pre-Seed, Funding Round, Seed
Spain

Portfolio highlights

Nextmol — Nextmol is your partner to accelerate chemicals discovery. Reduce time-to-market and get key insights about the behavior of your chemical molecules!
Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
The Blue Box Biomedical Solutions — Pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine

Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies

Investment focus

Genetics, Life Science, Biotechnology
Series A
Spain

Portfolio highlights

Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.

Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.

Investment focus

Financial Services, Software, FinTech
Debt Financing, Seed, Post-IPO Debt
Spain, United Kingdom, United States

Portfolio highlights

Tebrio — At the rate that the world is growing, we’ll only have enough food to feed 50% of our future population by 2050 and introducing novel proteins into the food value chain that are rich in amino acids and use less water and arable land is the only solution forward for mankind and the planet, which is why, in 2014, Adriana Casillas and Sabas de Diegofounded Tebrio, the world’s leading carbon-negative, zero-residue insect biotechnology company, which tackles climate change and the world food crisis by breeding and transforming rich amino acid mealworms into three main co-products: (i) sustainabe premium fish, pet and animal feed (ii) biofertilizer for plant nutrition that acts as a natural pest repellent (iii) chitosan to manufacture biodegradable plastic that disolves in water. Our carbon negative pilot farm produces 500 tons of co-products a year, does not emit greenhouse gases like ammonia or methane, uses 98% less water and 90% less arable land than other animal and plant protein farms, and is the only company in our industry in Spain that has received an ISO9001 certification, which guarantees the quality of our products. Thanks to our current operations, we have secured an undisclosed Series A round, which we are using to develop a EUR 50 million insect farm that will take us from a 500 tn to a 100.000 tns production of co-products a year and will be the largest of its kind in the world. Company Key Metrics: • Tebrio has 8 industrial patents in 150 countries • Tebrio’s operations are carbon negative, zero residue, and we do not emit greenhouse gases like ammonia or methane • With the same amount of natural resources, we are able to produce 500% more protein for fishmeal and animal feed than plant protein and livestock farms • Our protein for fish and animal feed is 90% digestible, 70% protein, high in essential amino acids and unsaturated fat • Tebrio was the first certified producer in the world of mealworm protein for fish and animal feed and biofertilizer for plant nutrition • Our tech powered biofertilizer has 10x more nutrients than other organic fertilizers and thanks to its properties, acts as a natural pest repellent • We are the only Spanish company in our industry with an ISO9001 certification • We are building the world’s largest insect farm, which will produce 100.000 tons of co-products a year for animal feed and plant fertilization • We use big data and 4.0 industries to industrially produce and control the Tenebrio Molitor insect
Embraer — Embraer SA is a Brazil-based holding company primarily engaged in the manufacture of aircraft. The company’s business activities are divided into three business segments: Commercial Aviation; Defense and Security Business, and Executive Aviation. The Commercial Aviation segment is involved in the development, production, and sale of commercialjets, as well as in the provision of support services, with emphasis on the regional aviation industry and aircraft leasing. The Defense and Security Business segment mainly includes the research, development, production and modification of defense aircrafts as well systems and software design. Through the Executive Aviation segment, the company is active in the development, production, and sale of business jets, the provision of support services related to this sector of the market, and aircraft leasing. Embraer has subsidiaries, affiliated companies, and representative offices in Brazil, the United States, France, Holland, and China, among others.
El Corte Ingles — El Corte Inglés is a business group with more than 80 years of history, upholding the same values as always. Our steadfast principles of ethical and responsible conduct allow us to evolve towards an omnichannel model more aligned with digitalisation, diversification and sustainability. This has meant a progress in the transformation of El CorteInglés from a retailer to a unique ecosystem. Without ever taking our eyes off the product and service quality, expertise, curated selections, guarantees and innovation we offer with the ultimate goal of making people's lives easier.

> smart projects

Investment focus

Health Care, Cooking, Medical
Seed, Funding Round
Spain

Portfolio highlights

Qualityfry — If you are looking for an automatic commercial deep fryer for your business, check the QualityFry ones. Check out and request a demonstration
Persei vivarium (Digital Health) — Persei vivarium is a digital health business dedicated to the creation of high-quality data collections that are based on real-word data for specific diseases. The technology facilitates the capture of clinical data from the physician’s daily clinicalpractice and from the patient based on a mobile appication for remote monitoring. This provides a more holistic view and better management of the disease. The information that is captured becomes a high-value resource that also, in a simple and easy process, generates high-quality research.
Transplant Biomedicals — Diabetes can be effectively controlled by following these best tips from Diabetes Guide. You will also get to know about the tips to manage diabetes naturally

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
United States, Germany, United Kingdom

Portfolio highlights

Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
ExpressionEdits — Redefining the status quo of protein expression
Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.

Pirate Impact is a Family office with focus on stage-agnostic direct investments in climate-tech & social impact companies in the EU & US.

Investment focus

Renewable Energy, Fuel, EdTech
Funding Round, Seed, Series C
Spain, Denmark, Germany

Portfolio highlights

XFuel — Next generation technology to produce sustainable low-carbon and powerful drop-in fuels for the Road, Marine and Aviation industries.
Labster — Labster empowers educators to reimagine their science courses with immersive online simulations. Request a demo to discover how Labster engages students, trains lab skills, and accelerates learning.
Voltfang — We integrate used electric car batteries into a battery storage system and thus build up a decentralized storage network.

Easo Ventures es una Sociedad de Capital Riesgo Vasca y Privada, cuyo objetivo es invertir en Startups y PYMES con proyectos de crecimiento.

Investment focus

Software, Manufacturing, Health Care
Seed, Funding Round, Series A
Spain

Portfolio highlights

Ingelia — Ingelia is a technology-based company specializing in R & D in the renewable energy sector. Ingelia is an SME based in Valencia (Spain) owned by multinational shareholders from Spain, Austria, England, and Italy.
Begas Motor — Begas has designed and manufactures the first engine for industrial vehicles powered 100% by LPG (Liquefied Petroleum Gas or AUTOGAS). Ability to remotorize vehicles and make them ecological with Euro VI certificate.
Trovant Technology — Trovant Technology specializes in the development of bio-based technologies for organic waste treatment and valorization, transforming this waste into bioenergy. They develop proprietary technology and tailor-made solutions, always keeping the market in mind. At the moment they are focusing on biogas upgrading and biomethane with UBI - BiologicalIntegral Biogas Upgrading.

Archipelago Next support and promote the entrepreneurial ecosystem.

Investment focus

Software, SaaS, Artificial Intelligence
Seed, Funding Round, Pre-Seed
Spain, United States

Portfolio highlights

Nware — NWARE, the new cloud gaming platform where you can play any game, anytime, anywhere! Stream and play your videogames in the cloud! Download now!
Nymiz — Harmonizing knowledge management through our data anonymization software for compliance with legal laws.
RawData — Agtech Agritech Agrotech Agriculture Farm Farming